Literature DB >> 24812342

PhenoNet: identification of key networks associated with disease phenotype.

Rotem Ben-Hamo1, Moriah Gidoni1, Sol Efroni1.   

Abstract

MOTIVATION: At the core of transcriptome analyses of cancer is a challenge to detect molecular differences affiliated with disease phenotypes. This approach has led to remarkable progress in identifying molecular signatures and in stratifying patients into clinical groups. Yet, despite this progress, many of the identified signatures are not robust enough to be clinically used and not consistent enough to provide a follow-up on molecular mechanisms.
RESULTS: To address these issues, we introduce PhenoNet, a novel algorithm for the identification of pathways and networks associated with different phenotypes. PhenoNet uses two types of input data: gene expression data (RMA, RPKM, FPKM, etc.) and phenotypic information, and integrates these data with curated pathways and protein-protein interaction information. Comprehensive iterations across all possible pathways and subnetworks result in the identification of key pathways or subnetworks that distinguish between the two phenotypes.
AVAILABILITY AND IMPLEMENTATION: Matlab code is available upon request. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2014        PMID: 24812342     DOI: 10.1093/bioinformatics/btu199

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  10 in total

1.  Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.

Authors:  Duane H Hamilton; Mario Roselli; Claudia Palena; Fiorella Guadagni; Patrizia Ferroni; Leopoldo Costarelli; Francesco Cavaliere; Mariateresa Taffuri
Journal:  Endocr Relat Cancer       Date:  2016-10       Impact factor: 5.678

2.  Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.

Authors:  Christopher R Heery; B Harpreet Singh; Myrna Rauckhorst; Jennifer L Marté; Renee N Donahue; Italia Grenga; Timothy C Rodell; William Dahut; Philip M Arlen; Ravi A Madan; Jeffrey Schlom; James L Gulley
Journal:  Cancer Immunol Res       Date:  2015-06-30       Impact factor: 11.151

3.  ChiPPI: a novel method for mapping chimeric protein-protein interactions uncovers selection principles of protein fusion events in cancer.

Authors:  Milana Frenkel-Morgenstern; Alessandro Gorohovski; Somnath Tagore; Vaishnovi Sekar; Miguel Vazquez; Alfonso Valencia
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

Review 4.  Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data.

Authors:  Jingwen Yan; Shannon L Risacher; Li Shen; Andrew J Saykin
Journal:  Brief Bioinform       Date:  2018-11-27       Impact factor: 11.622

5.  Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody.

Authors:  Duane H Hamilton; Romaine I Fernando; Jeffrey Schlom; Claudia Palena
Journal:  Oncotarget       Date:  2015-03-10

6.  Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited.

Authors:  Askar Obulkasim; Maarten Fornerod; Michel C Zwaan; Dirk Reinhardt; Marry M van den Heuvel-Eibrink
Journal:  BMC Bioinformatics       Date:  2015-09-23       Impact factor: 3.169

7.  ChainRank, a chain prioritisation method for contextualisation of biological networks.

Authors:  Ákos Tényi; Pedro de Atauri; David Gomez-Cabrero; Isaac Cano; Kim Clarke; Francesco Falciani; Marta Cascante; Josep Roca; Dieter Maier
Journal:  BMC Bioinformatics       Date:  2016-01-05       Impact factor: 3.169

8.  Identification of phenotype-specific networks from paired gene expression-cell shape imaging data.

Authors:  Charlie George Barker; Eirini Petsalaki; Girolamo Giudice; Julia Sero; Emmanuel Nsa Ekpenyong; Chris Bakal; Evangelia Petsalaki
Journal:  Genome Res       Date:  2022-02-23       Impact factor: 9.438

9.  hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements.

Authors:  Rotem Ben-Hamo; Alona Zilberberg; Helit Cohen; Sol Efroni
Journal:  Oncotarget       Date:  2016-04-26

10.  Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.

Authors:  Nahim Adnan; Chengwei Lei; Jianhua Ruan
Journal:  BMC Bioinformatics       Date:  2020-09-30       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.